NYSE: CVSACovista Inc Stock
$99.59+1.05 (+1.07%)
Updated Feb 24, 2026
CVSA Price
$99.59
Fair Value Price
N/A
Market Cap
$3.44B
52 Week Low
$86.26
52 Week High
$156.26
P/E
14.23x
P/B
2.49x
P/S
1.96x
PEG
1.03x
Dividend Yield
N/A
Revenue
$1.89B
Earnings
$253.25M
Gross Margin
57.4%
Operating Margin
19.77%
Profit Margin
13.4%
Debt to Equity
0.9
Operating Cash Flow
$428M
Beta
0.74
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CVSA Overview
Adtalem Global Education Inc. offers postsecondary degree and non-degree medical and healthcare education programs. Its Financial Services segment provides test preparation, certifications, conferences, seminars, memberships, and subscriptions. The company operates several for-profit higher education institutions including American University of the Caribbean School of Medicine. Adtalem Global Education was incorporated in 1987 and is based in Chicago, IL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CVSA's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Education
Industry Rating
A
CVSA
Ranked#5 of 23
Ranked#5 of 23
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $13.86 | B | |
| $75.43 | B | |
| $45.46 | B |
Be the first to know about important CVSA news, forecast changes, insider trades & much more!
CVSA News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CVSA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CVSA ($99.59) is trading above its intrinsic value of $77.82, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CVSA is good value based on its earnings relative to its share price (14.23x), compared to the US market average (44.5x)
P/E vs Market Valuation
CVSA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CVSA due diligence checks available for Premium users.
Valuation
CVSA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
14.23x
Industry
18.55x
Market
44.5x
CVSA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CVSA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CVSA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.49x
Industry
2.22x
CVSA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CVSA price to earnings growth (PEG)
For valuing profitable companies with growth potential
CVSA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CVSA's financial health
Profit margin
Revenue
$503.4M
Net Income
$76.4M
Profit Margin
15.2%
CVSA's Earnings (EBIT) of $373.39M... subscribe to Premium to read more.
Interest Coverage Financials
CVSA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.6B
Liabilities
$1.2B
Debt to equity
0.9
CVSA's short-term liabilities ($442.89M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CVSA's long-term liabilities ($793.03M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CVSA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CVSA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$29.7M
Investing
-$19.6M
Financing
-$217.7M
CVSA's operating cash flow ($427.90M)... subscribe to Premium to read more.
Debt Coverage Financials
CVSA vs Education Stocks
Covista Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.